These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16258818)

  • 1. Unselective use of intranasal mupirocin ointment for controlling propagation of methicillin-resistant Staphylococcus aureus in a thoracic surgery ward.
    Mori N; Hitomi S; Nakajima J; Okuzumi K; Murakami A; Kimura S
    J Infect Chemother; 2005 Oct; 11(5):231-3. PubMed ID: 16258818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
    Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
    J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open ward.
    Mayall B; Martin R; Keenan AM; Irving L; Leeson P; Lamb K
    J Hosp Infect; 1996 Apr; 32(4):257-66. PubMed ID: 8744510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients.
    Ridenour G; Lampen R; Federspiel J; Kritchevsky S; Wong E; Climo M
    Infect Control Hosp Epidemiol; 2007 Oct; 28(10):1155-61. PubMed ID: 17828692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.
    Sandri AM; Dalarosa MG; Ruschel de Alcantara L; da Silva Elias L; Zavascki AP
    Infect Control Hosp Epidemiol; 2006 Feb; 27(2):185-7. PubMed ID: 16465636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization.
    Mehta MS; Hacek DM; Kufner BA; Price C; Peterson LR
    Surg Infect (Larchmt); 2013 Feb; 14(1):69-72. PubMed ID: 23448592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment.
    Kauffman CA; Terpenning MS; He X; Zarins LT; Ramsey MA; Jorgensen KA; Sottile WS; Bradley SF
    Am J Med; 1993 Apr; 94(4):371-8. PubMed ID: 8475930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains.
    Semret M; Miller MA
    Infect Control Hosp Epidemiol; 2001 Sep; 22(9):578-80. PubMed ID: 11732789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit.
    Shiojima T; Ohki Y; Nako Y; Morikawa A; Okubo T; Iyobe S
    J Infect Chemother; 2003 Sep; 9(3):243-7. PubMed ID: 14513393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.
    Dupeyron C; Campillo B; Richardet JP; Soussy CJ
    J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) and Use of a Nasal Mupirocin Ointment in Oral Cancer Inpatients.
    Miyake M; Ohbayashi Y; Iwasaki A; Ogawa T; Nagahata S
    J Oral Maxillofac Surg; 2007 Nov; 65(11):2159-63. PubMed ID: 17954308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin].
    Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F
    Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery.
    Yano M; Doki Y; Inoue M; Tsujinaka T; Shiozaki H; Monden M
    Surg Today; 2000; 30(1):16-21. PubMed ID: 10648077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital.
    Vivoni AM; Santos KR; de-Oliveira MP; Giambiagi-deMarval M; Ferreira AL; Riley LW; Moreira BM
    Infect Control Hosp Epidemiol; 2005 Jul; 26(7):662-7. PubMed ID: 16092750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery.
    Suzuki Y; Kamigaki T; Fujino Y; Tominaga M; Ku Y; Kuroda Y
    Br J Surg; 2003 Sep; 90(9):1072-5. PubMed ID: 12945073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.
    Muller A; Talon D; Potier A; Belle E; Cappelier G; Bertrand X
    Crit Care; 2005 Jun; 9(3):R246-50. PubMed ID: 15987397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.
    Ellis MW; Griffith ME; Dooley DP; McLean JC; Jorgensen JH; Patterson JE; Davis KA; Hawley JS; Regules JA; Rivard RG; Gray PJ; Ceremuga JM; Dejoseph MA; Hospenthal DR
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3591-8. PubMed ID: 17682105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
    Wertheim HF; Vos MC
    Crit Care; 2005 Jun; 9(3):257-8. PubMed ID: 15987417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus.
    Watanabe H; Masaki H; Asoh N; Watanabe K; Oishi K; Kobayashi S; Sato A; Sugita R; Nagatake T
    J Clin Microbiol; 2001 Oct; 39(10):3775-7. PubMed ID: 11574616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.
    Jones JC; Rogers TJ; Brookmeyer P; Dunne WM; Storch GA; Coopersmith CM; Fraser VJ; Warren DK
    Clin Infect Dis; 2007 Sep; 45(5):541-7. PubMed ID: 17682986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.